OCIAD2 抗体 (AA 65-154)
Quick Overview for OCIAD2 抗体 (AA 65-154) (ABIN718031)
抗原
See all OCIAD2 抗体适用
宿主
克隆类型
标记
应用范围
-
-
抗原表位
- AA 65-154
-
预测反应
- Human,Mouse,Rat,Dog,Cow,Sheep,Pig,Horse,Rabbit
-
纯化方法
- Purified by Protein A.
-
免疫原
- KLH conjugated synthetic peptide derived from human OCIAD2
-
亚型
- IgG
-
-
anti-OCIA Domain Containing 2 (OCIAD2) (C-Term) antibody
OCIAD2 适用: 人 WB, ELISA, IF, IHC, IHC (p) 宿主: 兔 Polyclonal unconjugated
anti-OCIA Domain Containing 2 (OCIAD2) (AA 1-99) antibodyOCIAD2 适用: 人 WB, IF 宿主: 兔 Polyclonal unconjugated
anti-OCIA Domain Containing 2 (OCIAD2) (N-Term) antibodyOCIAD2 适用: 人, 小鼠, Pig, 兔, 猴 WB 宿主: 兔 Polyclonal unconjugated
anti-OCIA Domain Containing 2 (OCIAD2) (AA 72-121) antibodyOCIAD2 适用: 人 WB 宿主: 兔 Polyclonal unconjugated
anti-OCIA Domain Containing 2 (OCIAD2) (AA 1-154) antibodyOCIAD2 适用: 人 WB, IHC, IP, ICC 宿主: 兔 Polyclonal unconjugated
anti-OCIA Domain Containing 2 (OCIAD2) (N-Term) antibodyOCIAD2 适用: 人, 小鼠, 大鼠, Pig, 兔, Cow, 犬, 马 WB 宿主: 兔 Polyclonal unconjugated
-
-
应用备注
-
WB 1:300-5000
ELISA 1:500-1000
IHC-P 1:200-400
IHC-F 1:100-500
IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200 -
限制
- 仅限研究用
-
-
-
状态
- Liquid
-
浓度
- 1 μg/μL
-
缓冲液
- 0.01M TBS( pH 7.4) with 1 % BSA, 0.02 % Proclin300 and 50 % Glycerol.
-
储存液
- ProClin
-
注意事项
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
-
储存条件
- 4 °C,-20 °C
-
储存方法
- Shipped at 4°C. Store at -20°C for one year. Avoid repeated freeze/thaw cycles.
-
有效期
- 12 months
-
-
- OCIAD2 (OCIA Domain Containing 2 (OCIAD2))
-
别名
- OCIAD2
-
背景
-
Synonyms: OCAD2_HUMAN, OCIA domain containing 2, OCIA domain-containing protein 2, OCIAD2, ovarian carcinoma immunoreactive antigen, Ovarian carcinoma immunoreactive antigen like protein, Ovarian carcinoma immunoreactive antigen-like protein.
Background: OCIAD2 was identified by its sequence similarity with OCIAD1, and together OCIAD1 and OCIAD2 form the OCIA domain family. While the function of OCIAD2 is still unknown, its expression in adenocarcinoma with BAC component is significantly associated with a favorable prognosis and may serve as a marker for selecting tumors that are treatable by limited surgery.
-
基因ID
- 132299
抗原
-
